Skip to Content


UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antimigraine agent

Serotonin receptor antagonist

Chemical Name

Piperidine, 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]tien-4-ylidene)-1-metyl-

Foreign Names

  • Pizotifenum (Latin)
  • Pizotifen (German)
  • Pizotifène (French)
  • Pizotifeno (Spanish)

Generic Names

Brand Names

  • Antigrain
    Ibn Sina, Bangladesh
  • Antigrain TS
    Ibn Sina, Bangladesh
  • APPI-D
    DEEF, Oman
  • D-Fen
    Drug International, Bangladesh
  • Lysagor
    Kalbe, Indonesia
  • Migofen
    Techno, Bangladesh
  • Migranex
    Edruc, Bangladesh
  • Mosegor
    Novartis, Egypt; Novartis Farmaceutica, Spain
  • Pifen
    Opsonin, Bangladesh
  • Pitofen
    Medicon, Bangladesh
  • Pizo-A
    Acme, Bangladesh
  • Pizofen
    Navana, Bangladesh; Saiph, Tunisia; Simed, Tunisia
  • Pizofen-TS
    Navana, Bangladesh
  • Pizotifen-Sine Pharm
    Sine Pharm, China
  • Sandomigran
    Novartis, Slovakia; Novartis AH, South Africa
  • Zofen
    Aristopharma, Bangladesh
  • Zofen TS
    Aristopharma, Bangladesh
  • Zonil
    Apex, Bangladesh
  • Zonil-TS
    Apex, Bangladesh
  • Acugrain
    CCM Duopharma Biotech, Malaysia
  • Avidro
    Beximco, Bangladesh
  • Litec
    Novartis Healthcare, Philippines
  • Migranil
    Square, Bangladesh
  • Mosegor
    Novartis, Oman; Novartis, Thailand; SANDOZ, Philippines
  • Mozifen-EF
    T.O. Chemicals, Thailand
  • Pizomed
    Medifive, Thailand
  • Pizotifen Actavis
    Actavis UK, United Kingdom
  • Sandomigran
    Euro Registratie, Netherlands; Fisher Farma, Netherlands; Grupo Novartis, Spain; Novartis, Argentina; Novartis, Belgium; Novartis, Brazil; Novartis, Czech Republic; Novartis, Hong Kong; Novartis, Netherlands; Novartis, New Zealand; Novartis, Turkey; Novartis Farma, Italy; Novartis Pharmaceuticals, Australia; Phoenix Labs, Netherlands
  • Sandomigran DS
    Paladin, Canada
  • Sandomigrin
    Novartis, Denmark; Novartis, Iceland
  • Sanmigran
    CSP, France
  • Sanomigran
    Novartis, Ireland; Novartis Pharmaceuticals UK, United Kingdom


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.